NCT00263809View on ClinicalTrials.gov

Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Thrombocytopenia
Interventions
DEVICE

Pathogen Reduction Technology

Trial Locations (10)

25020

Centre Hospitalier Universitaire Jean Minjoz, Besançon

EFS Bourgogne - Franche-Comté, Besançon

33035

EFS Aquitaine, Bordeaux

33604

Centre Hospitalier Universitaire de Bordeaux, Pessac

38043

Centre Hospitalier Univesrsitaire A Michallon, La Tronche

38701

EFS Rhône-Alpes (Site de Grenoble), La Tronche

44011

EFS Pays de la Loire, Nantes

44035

Centre Hospitalier Universitaire Hôtel Dieu, Nantes

67000

Centre Hospitalier Régional Universitaire Hautepierre, Strasbourg

67065

EFS Alsace, Strasbourg

All Listed Sponsors
lead

Terumo BCTbio

INDUSTRY

NCT00263809 - Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products | Biotech Hunter | Biotech Hunter